Fasciola hepatica

Common liver fluke
Fasciola hepatica - adult worm Fasciola hepatica - adult worm
Scientific classification
Kingdom: Animalia Phylum: Platyhelminthes Class: Trematoda Subclass: Digenea Order: Echinostomida Family: Fasciolidae Genus: Fasciola Species: F. hepatica
Binomial name
Fasciola hepatica (Linnaeus, 1758)

This page is about microbiologic aspects of the organism(s).  For clinical aspects of the disease, see Fasciolosis.

Fasciolosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Fasciolosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
Endoscopy
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Fasciola hepatica On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Fasciola hepatica All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Fasciola hepatica
CDC on Fasciola hepatica
Fasciola hepatica in the news
Blogs on Fasciola hepatica
Directions to Hospitals Treating Fasciolosis
Risk calculators and risk factors for Fasciola hepatica

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Fasciola hepatica, also known as the common liver fluke or sheep liver fluke, is a parasitic flatworm of the class Trematoda, phylum Platyhelminthes that infects liver of a various mammals, including man. The disease caused by the fluke is called fascioliasis (also known as fasciolosis). F. hepatica is world-wide distributed and causes great economic losses in sheep and cattle.

Life cycle

In order to complete its life cycle, F. hepatica requires an aquatic snail as an intermediate host such as Galba truncatula, in which the parasite can reproduce asexually. From the snail, minute cercariae emerge and swim through pools of water in pasture, and encyst as metacercariae on near-by vegetation. From here, the metacercariae are ingested by the ruminant, or in some cases, by humans eating un-cooked foods such as water-cress. Contact with low pH in the stomach causes the early immature juvenile to begin the process of excystment. In the duodenum, the parasite breaks free of the metacercariae and burrows through the intestinal lining into the peritoneal cavity. The newly excysted juvenile does not feed at this stage, but once it finds the liver parenchyma after a period of days, feeding will start. This immature stage in the liver tissue is the pathogenic stage, causing anaemia and clinical signs sometimes observed in infected animals. The parasite browses on liver tissue for a period of up to 5-6 weeks and eventually finds its way to the bile duct where it matures into an adult and begins to produce eggs. Up to 25,000 eggs per day per fluke can be produced, and in a light infection, up to 500,000 eggs per day can be deposited onto pasture by a single sheep.

Disease biology

File:Egg of Fasciola hepatica 08G0041 lores.jpg

Egg of F. hepatica

In the United Kingdom, Fasciola hepatica is a frequent cause of disease in ruminants - this is most common between March and December. Cattle and sheep are infected when they consume the infectious stage of the parasite from low-lying, marshy pasture. The effects of liver fluke are referred to as fascioliasis, and include anaemia, weight loss and sub-mandibular oedema. Diarrhea is only an occasional consequence of liver fluke. Liver fluke is diagnosed by yellow-white eggs in the faeces. They are not distinguishable from the eggs of Fascioloides magna, although the eggs of F. magna are very rarely passed in sheep, goats or cattle.

A serious consequence of the liver damage caused by fascioliasis is that latent Clostridium novyi spores can be activated by the low oxygen conditions in the damaged tracts the parasite forms in the liver - this can lead to "black disease", caused by Clostridium novyi type B or immune-mediated haemolytic anaemia (IMHA) leading to haemoglobinuria caused by Clostridium novyi type D.

Treatment

The drug of choice in the treatment of fasciolosis is triclabendazole, a member of the benzimidazole family of anthelmintics. The drug works by preventing the polymerisation of the molecule tubulin into the cytoskeletal structures, microtubules. However, resistance of F. hepatica to triclabendazole has already been recorded in Australia and Ireland.

Antimicrobial Regimen

• Fasciola hepatica

• Preferred regimen: Triclabendazole 10 mg/kg PO one dose
• Note: Two-dose (double-dose) triclabendazole therapy can be given to patients who have severe or heavy Fasciola infections (many parasites) or who did not respond to single-dose therapy.

References

• Template:Aut (1995): Resistance of Fasciola hepatica to triclabendazole. Australian Veterinary Journal 72: 275–276.
• Template:Aut (1998): Vaccines in control of liver fluke infections in ruminants: current status and prospects. Irish Veterinary Journal 51: 520–525.